197 related articles for article (PubMed ID: 12006420)
1. Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
Nightingale JA; Rogers DF; Barnes PJ
Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420
[TBL] [Abstract][Full Text] [Related]
2. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
4. Salmeterol xinafoate in children on high dose inhaled steroids.
Russell G; Williams DA; Weller P; Price JF
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
[TBL] [Abstract][Full Text] [Related]
5. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
6. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.
Walters EH; Walters JA; Gibson PW
Cochrane Database Syst Rev; 2002; 2002(4):CD003901. PubMed ID: 12519616
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action.
van Noord JA; Smeets JJ; Raaijmakers JA; Bommer AM; Maesen FP
Eur Respir J; 1996 Aug; 9(8):1684-8. PubMed ID: 8866595
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Ulrik CS
Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.
Walters EH; Gibson PG; Lasserson TJ; Walters JA
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001385. PubMed ID: 17253458
[TBL] [Abstract][Full Text] [Related]
12. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A; Lipworth BJ
Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
[TBL] [Abstract][Full Text] [Related]
14. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L
Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599
[TBL] [Abstract][Full Text] [Related]
15. Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma.
Bousquet J; Aubert B; Bons J
Ann Allergy Asthma Immunol; 1996 Feb; 76(2):189-94. PubMed ID: 8595540
[TBL] [Abstract][Full Text] [Related]
16. A 4-week comparison of salmeterol and terbutaline in adult asthma.
Hermansson BA; Jenkins RJ
Allergy; 1995 Jul; 50(7):551-8. PubMed ID: 8588686
[TBL] [Abstract][Full Text] [Related]
17. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
18. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.
Cazzola M; Matera MG; Santangelo G; Vinciguerra A; Rossi F; D'Amato G
Respir Med; 1995 May; 89(5):357-62. PubMed ID: 7638371
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of salmeterol in childhood asthma.
Lenney W; Pedersen S; Boner AL; Ebbutt A; Jenkins MM
Eur J Pediatr; 1995 Dec; 154(12):983-90. PubMed ID: 8801107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]